Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Venous Thromboembolism

17 alpha-hydroxyprogesterone caproate has been researched along with Venous Thromboembolism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ananth, CV; D'Alton, ME; Friedman, AM; Gomez, D; Gyamfi-Bannerman, C; Huang, Y; Schuster, M; Wright, JD1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Venous Thromboembolism

ArticleYear
17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022, Volume: 35, Issue:25

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Progestins; Retrospective Studies; Venous Thromboembolism

2022